SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.

View Our Latest Analysis on SenesTech

SenesTech Stock Down 0.3 %

NASDAQ SNES opened at $2.90 on Tuesday. SenesTech has a one year low of $1.90 and a one year high of $13.30. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05. The business’s fifty day moving average is $2.92 and its 200-day moving average is $3.15.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Stories

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.